ReviewCureus2026
Exercise Collapse Associated With Sickle Cell Trait: Diagnosis, Treatment, Prevention, Current Controversies, and Gaps in the Literature.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sickle cell trait (SCT) is often benign but can be associated with occasional hemoglobin sickling, particularly in the setting of physical exertion. Screening for SCT, while controversial, reduces exertional events and death. Exertional sickling (ES) is the presumed and hypothesized etiology of collapse and death in athletes, where sickling, microvascular occlusion, and muscle necrosis result in ischemia, hyperkalemia, arrhythmia, and fulminant rhabdomyolysis. Due to the lack of clarity surrounding ES, the term exercise collapse associated with SCT (ECAST) was developed to describe individuals with SCT who suffer from an exertional collapse. Certain environmental and physical conditions may increase the likelihood of ECAST, but prompt recognition and treatment may reduce morbidity and mortality. This narrative review identifies current evidence regarding ECAST and discusses treatment, prevention, recent controversies, and gaps in the literature, highlighting that knowledge of SCT among athletes, warfighters, and their supervisors remains inadequate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.